Gene drives and societal narratives
By Brigitte Nerlich,
Making Science Public
| 08. 21. 2020
A review of nine previous posts about gene drives, most by the same author
Some days ago, I came across an interesting virtual conference (HT @Sarah_A_Hartley) about gene editing which includes a session on ‘societal narratives’. I have written quite a bit about societal narratives of gene editing, but more recently I became involved in the issue of ‘gene drive’, that is, “a system of biased inheritance in which the ability of a genetic element to pass from a parent to its offspring through sexual reproduction is enhanced”. This is a naturally occurring twist in the laws of inheritance that scientists can use (with the help of gene editing) “to develop [artificial] gene-drive modified organisms for public health, conservation, agriculture, and other societal purposes, for example, by suppressing populations of mosquito species that transmit human diseases such as malaria, dengue, Zika, and chikungunya among others” (Gene drives on the horizon, 2016).
I suddenly asked myself: Are there any societal narratives emerging around gene drives? Cloninghas societal narratives, recombinant DNA has societal narratives, genetic engineering has societal narratives (I can’t wait for @matthewcobb’s book about this), genomics has societal narratives, genetic...
Related Articles
Flag of South Africa; design by Frederick Brownell,
image by WikimediaCommons users.
Public domain, via Wikimedia Commons
What is the legal status of heritable human genome editing (HHGE)? In 2020, a comprehensive policy analysis by Baylis, Darnovsky, Hasson, and Krahn documented that more than 70 countries and an international treaty prohibit it, and that no country explicitly permits it. Policies in some countries were non-existent, ambiguous, or subject to possible amendment, but the general rule remained, even after one...
By Bernice Lottering, Gene Online | 11.08.2024
South Africa’s updated health-research ethics guidelines, which now include heritable human genome editing, have sparked concern among scientists. The revisions, made in May but only recently gaining attention, outline protocols for modifying genetic material in sperm, eggs, or embryos—changes...
By Jim Thomas, Scan the Horizon | 11.19.2024
It’s the wee hours of 2nd November 2024 in Cali, Colombia. In a large UN negotiating hall Colombian Environment Minister Susana Muhamed has slammed down the gavel on a decision that should send a jolt through the AI policy world. ...
By Ned Pagliarulo, BioPharmaDive | 11.05.2024
A medicine built around a more precise form of CRISPR gene editing appeared to work as designed in its first clinical trial test, developer Beam Therapeutics said Tuesday. But the death of a trial participant could renew concerns about an older...